TESC associated with poor prognosis enhances cancer stemness and migratory properties in liver cancer
Clinical and Experimental Medicine · 2024
DOI: 10.1007/s10238-024-01469-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Medicine, 2024. Verfasst von Peng Ye und 10 weiteren Autor:innen. Beteiligte Einrichtung: Infection Medicine Research Institute of Panyu District, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, Guangdong,…. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Liver Neoplasms, Calcium-Binding Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Science and Technology Project of Guangzhou Health Commission, the Science and Technology Project of Panyu District, Guangzhou, the Internal Scientific Research Fund of Guangzhou Panyu Central Hospital.
Abstract (Originalsprache)
Liver cancer stem cells (LCSCs) are responsible for recurrence, metastasis, and drug resistance in liver cancer. However, the genes responsible for inducing LCSCs have not been fully identified. Based on our previous study, we found that tescalcin (TESC), a calcium-binding EF hand protein that plays a crucial role in chromatin remodeling, transcriptional regulation, and epigenetic modifications, was up-regulated in LCSCs of spheroid cultures. By searching the Cancer Genome Atlas, International Cancer Genome Consortium, Human Protein Atlas, and Kaplan-Meier Plotter databases, we found that TESC expression was significantly elevated in liver cancer compared with that in normal liver tissue and was predictive of a decreased overall survival rate. Multivariate Cox analysis revealed TESC to be an independent prognostic factor for survival. High TESC expression was positively associated with cancer stem cell pathways, cancer stem cell surface markers, stemness transcription factors, epithelial-mesenchymal transition (EMT) factors, immune checkpoint proteins, and various cancer-related biological processes in liver cancer. Furthermore, TESC was implicated as promoting cancer stem cell properties through its influence on EMT. We demonstrated that TESC is a novel stemness-related gene that can serve as an independent prognostic factor for liver cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infection Medicine Research Institute of Panyu District, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
- Affiliated Cancer Hospital and Institute, Guangzhou Medical University, Guangzhou, Guangdong, China.
- Graduate School of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, Guangdong, China.
- Department of Biomedical Science, College of Medicine, and Program in Biomedical Sciences and Engineering, Inha University, Incheon, South Korea.
- Institute of Translational Medicine and New Drug Development, China Medical University, Taichung, Taiwan. kwhsu@mail.cmu.edu.tw.
- Affiliated Cancer Hospital and Institute, Guangzhou Medical University, Guangzhou, Guangdong, China. sure83@gzhmu.edu.cn.
Förderung
- the Science and Technology Project of Guangzhou Health Commission
- the Science and Technology Project of Panyu District, Guangzhou
- the Internal Scientific Research Fund of Guangzhou Panyu Central Hospital
- the National Natural Science Foundation of China
- Project of Educational Commission of Guangdong Province of China
- the YingTsai Young Scholar Award
- the National Science and Technology Council, Taiwan
Zitieren
APA
Ye, P., Luo, S., Huang, J., Fu, X., Chi, X., Cha, J. H., Chen, Y., Mai, Y., Hsu, K. W., Yan, X., & Yang, W. H. (2024). TESC associated with poor prognosis enhances cancer stemness and migratory properties in liver cancer. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-024-01469-y
Vancouver
Ye P, Luo S, Huang J, Fu X, Chi X, Cha JH, et al. TESC associated with poor prognosis enhances cancer stemness and migratory properties in liver cancer. Clinical and Experimental Medicine. 2024. doi:10.1007/s10238-024-01469-y
BibTeX
@article{Ye2024,
author = {Ye, Peng and Luo, Shahang and Huang, Junyu and Fu, Xihua and Chi, Xiaoxia and Cha, Jong-Ho and Chen, Yumei and Mai, Yanjun and Hsu, Kai-Wen and Yan, Xiuwen and Yang, Wen-Hao},
title = {TESC associated with poor prognosis enhances cancer stemness and migratory properties in liver cancer},
journal = {Clinical and Experimental Medicine},
year = {2024},
doi = {10.1007/s10238-024-01469-y}
}
EUVIMED